Tolterodine is a novel candidate for assessing CYP3A4 activity through metabolic volatiles to predict drug responses
Abstract Cytochrome P450 (CYP) 3A4 plays a major role in drug metabolism. Its activity could be determined by non-invasive and cost-effective assays, such as breath analysis, for the personalised monitoring of drug response. For the first time, we identify an isotopically unlabelled CYP3A4 substrate...
Saved in:
| Main Authors: | Valentina Stock, Rebecca Hofer, Franziska Lochmann, Vera Spanke, Klaus R. Liedl, Jakob Troppmair, Thierry Langer, Hubert Gstach, Christian Dank, Chris A. Mayhew, Sarah Kammerer, Veronika Ruzsanyi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-01-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-86450-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transdermal delivery of tolterodine tartrate for overactive bladder treatment: In vitro and in vivo evaluation
by: Rajabalaya Rajan, et al.
Published: (2017-09-01) -
Effects of bortezomib on intracellular antioxidant and apoptosis in HepG2cells
by: Grażyna Świderska-Kołacz, et al.
Published: (2025-04-01) -
Research on Cryopreservation Conditions of Attached HepG2 Cells on PDMS-glass Microfluidic Chip
by: Zhou Xinli, et al.
Published: (2020-01-01) -
Lipid-Lowering Potential of Almond Hulls (Quercetin, Baicalein, and Kaempferol): Insights from Network Pharmacology and Molecular Dynamics
by: Qiming Miao, et al.
Published: (2025-06-01) -
Establishment and Evaluation of HepG2 Cell Insulin Resistance Model
by: Meng Z, et al.
Published: (2025-07-01)